Big data analytics and competitive intelligence play many roles in the modern world, for all levels of business and corporate structures, nonprofit agencies, research and development organizations and many other entities. When big data and competitive intelligence work together, it can be particularly advantageous. This type of business process optimization is especially beneficial for the life sciences industry. There are several reasons for this, as you will see below.
Analytical limitations can reduce the effectiveness of the data being produced in the life sciences industry, but this can be mitigated with a big data analytics solution that examines the large amounts of varied data being produced, studied and transmitted. When used effectively, this can reveal valuable information, such as the unknown correlations and hidden patterns of the various types of data produced in medical research. This, in turn, helps provide a competitive advantage for the organization that is gaining this intelligence, as they are then able to market and optimize themselves more effectively in order to increase productivity and revenue. Organizations in the life sciences industry, including big research and medical/pharmaceutical companies, are also able to make better strategic decisions with more competitive intelligence. This can be defined as the process of gathering, analyzing, defining and distributing the intelligence that a business or organization has about their competitors, products and customers.
A business consulting firm can help organizations in the life sciences industry achieve these intelligence and data analytics goals through a variety of processes and cutting-edge software tools. There are many advantages to combining and leveraging big data analytics and competitive intelligence for the life sciences industry. The following five advantages, however, may be the most compelling:
- Leveraging this powerful combination of analytical and intelligence tools can provide the right sort of environment to integrate many different types of critical data that are integral to the life sciences industry, including medical studies, patient records, payer information and more. This ultimately has the potential to help support many major industry health care initiatives.
- These tools can help an organization run powerful, predictive, statistical analytics against large volumes of data, including transactional data as well as a combination of unstructured and transactional data. This large volume of data supply enables the leaders of the life sciences industry to achieve rapid results and increase the probability of precise projections.
- A big data analytics solution can be especially advantageous in the case of monitoring risk in clinical trials, as it enables research organizations to identify critical aspects of adverse events in their trials, to utilize large target data to spot legitimate trends and to identify legitimately concerning outliers in their study results early on.
- Pharmaceutical research laboratories can use these solutions to leverage clinical study data, external data from organizations like the National Institutes of Health, managed market data, scientific data, sentiment data and many other types of pertinent information. This allows researchers to keep track of, evaluate the effectiveness of and predict the marketability of drugs during testing.
- Personal medicine applications also gain valuable support from these powerful analytical tools that combine big data and competitive intelligence. Big data can help researchers to analyze individuals’ medical data signatures against massive sets of patient data in order to find trends in the health outcomes of consumers.
This list of five advantages is merely a brief description of the possibilities found in big data and competitive intelligence solutions for the life sciences industry. Business consulting firms are hard at work helping the leaders in this field utilize the massive amounts of data they collect and transmit more effectively, resulting in better products and procedures for consumers and patients to enjoy.
- A look ahead: Inspection Readiness and SCOPE Summit 2015
- Innovation Re-thought and Applied to Gross-to-Net (Part Two: Program Execution)
- Retain and Preserve Your Content: Staying Compliant in 2015
- Innovation Re-thought and Applied to Gross-to-Net (Part One: Business Process Execution)
- How to Increase Compliance in Financial Services with an ECM Strategy